SCHEDULE: Asymmetry Point LP Discloses NexGel Stake

Asymmetry Point LP, along with its General Partner Asymmetry Point Capital LLC and fund manager Aviv Argaman, has reported beneficial ownership of 745,000 shares of NexGel, Inc. common stock, representing 8.8% of the class.

Summary

• Asymmetry Point LP, Asymmetry Point Capital LLC, and Mr. Aviv Argaman have jointly filed a Schedule 13G, indicating their beneficial ownership of NexGel, Inc. common stock.
• The total number of shares beneficially owned is 745,000.
• This holding represents 8.8% of the total class of NexGel, Inc. common stock.
• The percentage ownership is calculated based on 8,475,693 shares outstanding as of March 31, 2026, as reported in NexGel's Form 10-K for the year ended December 31, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not provide new operational or financial performance information about NexGel, Inc.

Positives

• Significant stake of 8.8% in NexGel, Inc. common stock reported by Asymmetry Point entities.
• Clear disclosure of beneficial ownership, providing transparency to the market.

Risks

• The filing does not explicitly detail any risks associated with this ownership stake.
• Potential for future changes in ownership or investment strategy by Asymmetry Point entities could impact NexGel's stock.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding NexGel, Inc.'s future performance.

Management Comments

• Mr. Aviv Argaman certifies that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than in connection with a nomination under Rule 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors crossing certain ownership thresholds. This filing indicates a significant passive investment by Asymmetry Point entities in NexGel, Inc., a company operating in the medical technology or related sector.

Stakeholder Impact

• Shareholders: Increased transparency regarding a significant beneficial owner, potentially influencing market perception.
• Management of NexGel, Inc.: Awareness of a substantial passive investor.
• Regulators: Compliance with SEC disclosure requirements.

Next Steps

• Asymmetry Point LP, Asymmetry Point Capital LLC, and Mr. Aviv Argaman will continue to hold their beneficial ownership of NexGel, Inc. common stock.
• Further filings may be required if ownership levels change significantly.

Key Dates

Keywords

NexGel, Schedule 13G, Asymmetry Point LP, Asymmetry Point Capital LLC, Aviv Argaman, beneficial ownership, common stock, SEC filing, investment